Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Millions of Americans carry HSA and FSA balances each year that expire unused. GLP-1 receptor agonist medications like semaglutide and tirzepatide now represent an IRS-eligible expense, meaning you can direct pre-tax dollars toward your weight loss treatment. PlexusDx compounds all medications in licensed 503A pharmacies and accepts HSA and FSA payments across all 50 states, with no insurance requirement.
Are GLP-1 Medications Eligible HSA and FSA Expenses?
The IRS classifies injectable and oral GLP-1 receptor agonists as qualified medical expenses under both Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). This classification applies whether you receive medications from a traditional pharmacy or a licensed compounding pharmacy. PlexusDx compounds semaglutide and tirzepatide in 503A pharmacies and qualifies for both HSA and FSA reimbursement, allowing you to pay with pre-tax funds.
Using HSA or FSA funds for GLP-1 therapy reduces your out-of-pocket cost significantly. For example, someone in a 25% tax bracket who spends $149 monthly on compounded semaglutide injection through PlexusDx saves approximately $37 per month in taxes—or $444 annually—by paying with HSA or FSA dollars instead of after-tax income. This advantage applies to all PlexusDx offerings, including oral semaglutide, tirzepatide, and the GLP-Squared combination protocol.
How to Use Your HSA or FSA for PlexusDx Treatment
PlexusDx accepts HSA and FSA debit cards at checkout, just as you would use them for any other eligible healthcare expense. During enrollment, patients select their GLP-1 medication—such as semaglutide injection starting at $149 monthly—and choose their payment method. Your HSA or FSA provider issues a debit card linked to your account balance, and PlexusDx processes this card like standard payment, with no separate documentation required at the time of purchase.
If your HSA or FSA uses a reimbursement model rather than a debit card, you can pay PlexusDx out-of-pocket and then submit an itemized receipt to your plan administrator for reimbursement. PlexusDx provides detailed invoices listing the medication, quantity, and date of service—all information your plan needs to process the claim. Many employers and insurance administrators now fast-track GLP-1 reimbursements given their clinical evidence in weight management.
Key Differences Between HSA and FSA for GLP-1 Payment
Health Savings Accounts (HSA) offer more flexibility than Flexible Spending Accounts (FSA). An HSA is available only if you carry a high-deductible health plan (HDHP), but funds roll over year to year indefinitely, grow tax-free if invested, and remain yours to use after retirement. This makes HSA an ideal vehicle for ongoing GLP-1 therapy, which many patients continue for 12 months or longer. An FSA, by contrast, is offered through many employers regardless of insurance type, but typically operates on a use-it-or-lose-it annual cycle, meaning unused funds forfeit at year-end.
PlexusDx serves patients with either account type. If you have an HSA, you can budget your GLP-1 cost across multiple years and carry a balance. If you have an FSA with a $3,050 annual maximum (2024 limit), a 12-month course of semaglutide injection at $149 monthly totals $1,788—well within your FSA limit and leaving room for other medical expenses. Both account types offer identical tax advantages at the point of payment.
Why Choose PlexusDx for HSA-Eligible GLP-1 Therapy
PlexusDx combines transparent, flat monthly pricing with HSA and FSA eligibility to simplify weight loss therapy. Compounded semaglutide injection starts at $149 per month, and your dose may increase during treatment—but your price remains flat. No insurance navigation, no membership fees, and no hidden charges means your HSA or FSA dollars stretch further than with traditional healthcare channels. PlexusDx serves all 50 states and compounds medications in licensed 503A pharmacies certified for safety and quality.
Patients who want personalized GLP-1 selection can add the Precision Peptide Genetic Test ($99 add-on after first month of treatment) to map 14 metabolic pathways and 150+ genetic insights related to GLP-1 receptor function, glucagon-dependent insulinotropic peptide (GIPR) response, and appetite-regulation genes like FTO and MC4R. This genetic roadmap helps PlexusDx clinical teams recommend semaglutide, tirzepatide, or the GLP-Squared dual-compound protocol based on your unique peptide pathway profile—optimizing outcomes before your HSA or FSA dollars are spent.
Plan Ahead: Maximizing Your HSA or FSA for GLP-1
If you carry an HSA and are considering GLP-1 therapy, plan to enroll before your annual HSA contribution limit is reached. The 2024 HSA contribution cap is $4,150 for individual coverage and $8,300 for family coverage. These funds can be allocated toward medications like PlexusDx semaglutide or tirzepatide without reducing your ability to cover other qualified medical expenses. HSA funds can also grow in an investment account if you don't spend them immediately, effectively lowering your long-term cost of GLP-1 therapy.
FSA participants should check their plan's annual election limits and carryover rules before the open enrollment period. Some employers offer a $610 carryover allowance or a 2.5-month grace period, meaning you may retain up to $610 of unused FSA funds from one year into the next. If your employer offers this flexibility, you could spread a PlexusDx GLP-1 commitment across fiscal year boundaries. Always confirm your specific plan rules with your human resources or benefits administrator to avoid forfeiting eligible funds.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I really use my HSA to pay for compounded semaglutide from PlexusDx?
Yes. Compounded semaglutide from licensed 503A pharmacies qualifies as an IRS-eligible medical expense under HSA and FSA plans. PlexusDx accepts HSA and FSA debit cards directly, and you can also pay out-of-pocket and request reimbursement using the itemized receipt PlexusDx provides.
Is compounded GLP-1 from PlexusDx FDA-approved?
PlexusDx compounds semaglutide and tirzepatide in licensed 503A compounding pharmacies, which operate under FDA oversight but do not receive FDA approval for individual compounds. The active pharmaceutical ingredients themselves are FDA-recognized. Your provider evaluates medical appropriateness regardless of compounding source.
How much can I save by using my HSA or FSA for PlexusDx semaglutide?
Semaglutide injection at PlexusDx starts at $149 monthly. Using HSA or FSA pre-tax dollars eliminates federal income tax, and depending on your tax bracket, can save $30–$50 per month, or $360–$600 annually. Additional savings apply if your state also taxes medical expenses.
What happens if I don't use all my FSA balance before the year ends?
Standard FSA plans operate on a use-it-or-lose-it basis, and unused funds forfeit after the plan year ends. Some employers allow a $610 carryover or a 2.5-month grace period. Contact your benefits administrator to learn your plan's rules. If you have flexibility, you could time GLP-1 enrollment to use FSA funds before the deadline.
Can the Precision Peptide Genetic Test be paid with HSA or FSA?
Yes. The PlexusDx Precision Peptide Genetic Test ($99 add-on) maps 14 metabolic pathways and 150+ genetic insights related to GLP-1 receptor and appetite-regulation genes. As a medical diagnostic test, it qualifies for HSA and FSA payment and helps guide personalized GLP-1 selection before treatment begins.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Are People Taking Ozempic for Weight Loss? Exploring the Phenomenon
The Most Effective Place to Inject Tirzepatide for Optimal Weight Loss